Literature DB >> 23912765

Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention.

Omodele Awoniyi1, Rabia Rehman, Samuel Dagogo-Jack.   

Abstract

Hypoglycemia is uncommon in the general, nondiabetic population but occurs frequently in persons with diabetes treated with insulin or insulin secretagogues. Thus, iatrogenic hypoglycemia explains the majority of cases among persons with type 1 diabetes (T1DM). Since T1DM is characterized by absolute insulin dependence, the current imperfections in insulin replacement therapies often lead to a mismatch between caloric supply and circulating insulin levels, thus increasing the risk for glycemic fluctuations. Hypoglycemia is the limiting factor to excellent glycemic control in insulin-treated subjects. Intensification of glycemic control was associated with a 300 % increase in the rate of hypoglycemia in the Diabetes Control and Complications Trial. Recent measurements using continuous glucose monitoring reveal an alarming rate of daytime and nocturnal episodes of hypoglycemia in patients with T1DM. Etiological factors underlying hypoglycemia in T1DM include predictable triggers (skipped meals, exercise, insulin over dosage) as well as defective counterregulation, a component of hypoglycemia-associated autonomic failure.

Entities:  

Mesh:

Year:  2013        PMID: 23912765     DOI: 10.1007/s11892-013-0411-y

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  99 in total

Review 1.  Recent advances in the prevention of hypoglycemia in type 1 diabetes.

Authors:  Jaime M Realsen; H Peter Chase
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

2.  Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.

Authors:  Marion J Franz; John P Bantle; Christine A Beebe; John D Brunzell; Jean-Louis Chiasson; Abhimanyu Garg; Lea Ann Holzmeister; Byron Hoogwerf; Elizabeth Mayer-Davis; Arshag D Mooradian; Jonathan Q Purnell; Madelyn Wheeler
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

3.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

4.  Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus.

Authors:  Daniel J Cox; Boris Kovatchev; Dragomir Koev; Lidia Koeva; Svetoslav Dachev; Dimitar Tcharaktchiev; Anastassia Protopopova; Linda Gonder-Frederick; William Clarke
Journal:  Int J Behav Med       Date:  2004

Review 5.  Hypoglycemia risk reduction in type 1 diabetes.

Authors:  P E Cryer
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

6.  Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation.

Authors:  Michael A DeRosa; Philip E Cryer
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-02-17       Impact factor: 4.310

Review 7.  Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM.

Authors:  P E Cryer
Journal:  Diabetes       Date:  1994-11       Impact factor: 9.461

8.  Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes.

Authors:  U Pedersen-Bjergaard; B Agerholm-Larsen; S Pramming; P Hougaard; B Thorsteinsson
Journal:  Diabetologia       Date:  2002-12-18       Impact factor: 10.122

9.  Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.

Authors: 
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

10.  Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009.

Authors:  Susan M O'Connell; Matthew N Cooper; Max K Bulsara; Elizabeth A Davis; Timothy W Jones
Journal:  Diabetes Care       Date:  2011-09-16       Impact factor: 19.112

View more
  13 in total

1.  A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy.

Authors:  Cari Berget; Laurel H Messer; Gregory P Forlenza
Journal:  Diabetes Spectr       Date:  2019-08

Review 2.  A role for leptin-regulated neurocircuitry in subordination stress.

Authors:  Jonathan N Flak
Journal:  Physiol Behav       Date:  2016-11-22

3.  Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery.

Authors:  Ram Weiss; Satish K Garg; Richard M Bergenstal; David C Klonoff; Bruce W Bode; Timothy S Bailey; James Thrasher; Frank Schwartz; John B Welsh; Francine R Kaufman
Journal:  J Diabetes Sci Technol       Date:  2015-05-18

4.  Altered Caffeine Metabolism Is Associated With Recurrent Hypoglycemia in Type 2 Diabetes Mellitus: A UPLC-MS-Based Untargeted Metabolomics Study.

Authors:  Wang Lijing; Ke Sujie; Wang Linxi; Huang Lishan; Qi Liqin; Zhan Zhidong; Wu Kejun; Zhang Mengjun; Liu Xiaoying; Liu Xiaohong; Liu Libin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

5.  Engineered insulin secretion from neuroendocrine cells isolated from human thyroid.

Authors:  Peter M Thulé; Dingwu Jia; Susan Safley; Kereen Gordon; Graham Barber; Hong Yi; Soumya Nalli; Muhittin Onderci; Jyotirmay Sharma; John Shires; Collin J Weber
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

6.  Leptin-inhibited PBN neurons enhance responses to hypoglycemia in negative energy balance.

Authors:  Jonathan N Flak; Christa M Patterson; Alastair S Garfield; Giuseppe D'Agostino; Paulette B Goforth; Amy K Sutton; Paige A Malec; Jenny-Marie T Wong; Mark Germani; Justin C Jones; Michael Rajala; Leslie Satin; Christopher J Rhodes; David P Olson; Robert T Kennedy; Lora K Heisler; Martin G Myers
Journal:  Nat Neurosci       Date:  2014-11-10       Impact factor: 24.884

7.  Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).

Authors:  T R Pieber; S Famulla; J Eilbracht; J Cescutti; N Soleymanlou; O E Johansen; H J Woerle; U C Broedl; S Kaspers
Journal:  Diabetes Obes Metab       Date:  2015-06-24       Impact factor: 6.577

8.  Impact of insulin pump on quality of life of diabetic patients.

Authors:  Haider Ghazanfar; Syed Wajih Rizvi; Aliya Khurram; Fizza Orooj; Iman Qaiser
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug

9.  Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome).

Authors:  Samuel Dagogo-Jack
Journal:  Diabetes Care       Date:  2015-12       Impact factor: 19.112

Review 10.  Devices for continuous monitoring of glucose: update in technology.

Authors:  Ana María Gómez; Diana Cristina Henao Carrillo; Oscar Mauricio Muñoz Velandia
Journal:  Med Devices (Auckl)       Date:  2017-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.